LINEX

This brand name is authorized in Lithuania.

Active ingredients

The drug LINEX contains a combination of these active pharmaceutical ingredients (APIs):

`1`	Lactobacillus acidophilus (sp. L.gasseri) UNII `1PRR1V42V5` - LACTOBACILLUS ACIDOPHILUS
	Read more about Lactic acid bacteria
`2`	Lactic acid bacteria UNII `EF3U3H7I76` - BIFIDOBACTERIUM LONGUM INFANTIS
	Read more about Lactic acid bacteria
`3`	Lactic acid bacteria UNII `34YYS7G16P` - ENTEROCOCCUS FAECIUM
	Read more about Lactic acid bacteria

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A07FA51	Lactic acid producing organisms, combinations	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07F Antidiarrheal microorganisms → A07FA Antidiarrheal microorganisms
Discover more medicines within A07FA51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
LT	Valstybinė vaistų kontrolės tarnyba	1006814, 1026923

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.